Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubeta N Matin

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Dermatology|May 9, 2024
Widening the scope of artificial intelligence applications in dermatologyRubeta N Matin
The Lancet. Digital Health|September 29, 2023
Diagnosis of suspicious pigmented lesions in specialist settings with artificial intelligenceRubeta N Matin, Jacqueline Dinnes
Journal of Cutaneous Pathology|November 27, 2020
Cutaneous Epstein-Barr virus-associated smooth muscle tumor in immunosuppressionRubeta N Matin, Eleni Ieremia
British Journal of Cancer|March 20, 2021
AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulationRubeta N Matin, Jacqueline Dinnes
European Journal of Dermatology : EJD|October 1, 2014
Residents'corner August 2014. Clues in DeRmosCopy: dermoscopic features to aid earlier diagnosis?Ben A Esdaile, Rubeta N Matin
European Journal of Dermatology : EJD|August 8, 2019
Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanomaSanju Arianayagam, Eleni Ieremia, Rubeta N Matin
The British Journal of Dermatology|July 6, 2023
Leveraging large language models in dermatologyRubeta N Matin, Eleni Linos, Neil Rajan
JAMA Dermatology|July 21, 2018
Spiky Skin in a Renal Transplant RecipientFlora Poon, Olivia Espinosa, Rubeta N Matin
Dermatologic Clinics|October 15, 2025
Regulatory and Legal Considerations with Artificial Intelligence in DermatologyNisha Shah, Miranda Mourby, Rubeta N Matin
Clinical and Experimental Dermatology|March 12, 2026
Acute generalised exanthematous pustulosis in a patient on pembrolizumab for palliative treatment of lung adenocarcinomaEbiuwa A Ibude, Christopher Stonard, Rubeta N Matin
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Dermatology|May 9, 2024
Widening the scope of artificial intelligence applications in dermatologyRubeta N Matin
The Lancet. Digital Health|September 29, 2023
Diagnosis of suspicious pigmented lesions in specialist settings with artificial intelligenceRubeta N Matin, Jacqueline Dinnes
Journal of Cutaneous Pathology|November 27, 2020
Cutaneous Epstein-Barr virus-associated smooth muscle tumor in immunosuppressionRubeta N Matin, Eleni Ieremia
British Journal of Cancer|March 20, 2021
AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulationRubeta N Matin, Jacqueline Dinnes
European Journal of Dermatology : EJD|October 1, 2014
Residents'corner August 2014. Clues in DeRmosCopy: dermoscopic features to aid earlier diagnosis?Ben A Esdaile, Rubeta N Matin
European Journal of Dermatology : EJD|August 8, 2019
Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanomaSanju Arianayagam, Eleni Ieremia, Rubeta N Matin
The British Journal of Dermatology|July 6, 2023
Leveraging large language models in dermatologyRubeta N Matin, Eleni Linos, Neil Rajan
JAMA Dermatology|July 21, 2018
Spiky Skin in a Renal Transplant RecipientFlora Poon, Olivia Espinosa, Rubeta N Matin
Dermatologic Clinics|October 15, 2025
Regulatory and Legal Considerations with Artificial Intelligence in DermatologyNisha Shah, Miranda Mourby, Rubeta N Matin
Clinical and Experimental Dermatology|March 12, 2026
Acute generalised exanthematous pustulosis in a patient on pembrolizumab for palliative treatment of lung adenocarcinomaEbiuwa A Ibude, Christopher Stonard, Rubeta N Matin
Pageof 8